The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report

被引：0

作者：

Choi, Yu Jeong ^{[1
]}

Kook, Hye Won ^{[2
]}

Lee, Seung-Tae ^{[1
,3
]}

Song, Jaewoo ^{[1
]}

Choi, Jong Rak ^{[1
,3
]}

Cheong, June-Won ^{[2
]}

Shin, Saeam ^{[1
]}

机构：

[1] Yonsei Univ, Severance Hosp, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[2] Yonsei Univ, Coll Med, Div Hematol, Severance Hosp,Dept Internal Med, 50 Yonsei Ro, Seoul 03722, South Korea

[3] Dxome co Ltd, Seongnam, South Korea

来源：

LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 13期

基金：

新加坡国家研究基金会;

关键词：

POLYCYTHEMIA-VERA; PROGNOSIS;

D O I：

10.1080/10428194.2024.2385498

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2040 / 2043

页数：4

共 50 条

[41] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
Kim, A. S.
Kressin, M. K.
Mosse, C. A.
Seegmiller, A.
LABORATORY INVESTIGATION, 2012, 92 : 347A - 347A
[42] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
Kim, A. S.
Kressin, M. K.
Mosse, C. A.
Seegmiller, A.
MODERN PATHOLOGY, 2012, 25 : 347A - 347A
[43] Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse
Press, Richard D.
Eickelberg, Garrett
Froman, Allison
Yang, Fei
Stentz, Alex
Flatley, Ellen M.
Fan, Guang
Lim, Jeong Y.
Meyers, Gabrielle
Maziarz, Richard T.
Cook, Rachel J.
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) : 902 - 912
[44] COMPARISON OF NEXT GENERATION SEQUENCING VERSUS SINGLE ANALYTE TESTS FOR SOMATIC MUTATION DETECTION IN ACUTE MYELOID LEUKEMIA, MYELOPROLIFERATIVE NEOPLASM AND SOLID TUMORS
McCready, Elizabeth
Leber, Brian
Waye, John
Difrancesco, Teresa
Eng, Barry
Arts, Heleen
Butcher, Martin
Jeurgens, Rosalyn
Grafodatskya, Daria
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 72 - 72
[45] Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing
Patkar, Nikhil
Shaikh, Anam Fatima
Kakirde, Chinmayee
Salve, Rakhi
Bhanshe, Prasanna
Chatterjee, Gaurav
Rajpal, Sweta
Joshi, Swapnali
Chaudhary, Shruti
Kodgule, Rohan
Shetty, Dhanlaxmi Lalit
Jain, Hasmukh
Bagal, Bhausaheb
Menon, Hari
Khattry, Navin
Sengar, Manju
Tembhare, Prashant
Subramanian, Papagudi Ganesan
Gujral, Sumeet
BLOOD, 2020, 136
[46] Minimal Residual Disease Detection in Adults with Acute Lymphoblastic Leukemia By Next Generation Sequencing: Impact on Clinical Outcomes
Cervantes, Lissette
Wang, Lan
Yaghmour, George
Varnavski, Andrei
Siddiqi, Imran
BLOOD, 2020, 136
[47] Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
Cao, Xin-xin
Cai, Hao
Mao, Yue-ying
Wu, Qi
Zhang, Lu
Zhou, Dao-bin
Li, Jian
CANCER CELL INTERNATIONAL, 2018, 18
[48] Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma
Lin, Chuanming
Jian, Qijie
Huang, Zoufang
Xie, Shuiling
Xin, Liuyan
Wu, Haiyan
Pang, Fei
Liao, Changfeng
Chen, Yijian
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[49] Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
Xin-xin Cao
Hao Cai
Yue-ying Mao
Qi Wu
Lu Zhang
Dao-bin Zhou
Jian Li
Cancer Cell International, 18
[50] RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Kim, Taehyung
Moon, Joon Ho
Ahn, Jae-Sook
Tyndel, Marc S.
Lee, Seung-Shin
Ahn, Seo-Yeon
Jung, Sung-Hoon
Yang, Deok-Hwan
Lee, Je-Jung
Choi, Seunghyun
Lee, Ja-yeon
Lee, Yoojin
Sohn, Sang Kyun
Zhang, Zhaolei
Kim, Hyeoung-Joon
Kim, Dennis Dong Hwan
BLOOD, 2018, 132

← 1 2 3 4 5 →